Use of chemotherapy near the end of life: what factors matter? von Rochigneux, P., Raoul, J.L., Beaussant, Y., Aubry, R., Goldwasser, F., Tournigand, C., Morin, L.

Volltext

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy von Wlosik, J., Fattori, S., Rochigneux, P., Goncalves, A., Olive, D., Chretien, A. S.

Volltext

End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study von Gallais Sérézal, I., Beaussant, Y., Rochigneux, P., Tournigand, C., Aubry, R., Lindelöf, B., Morin, L.

Volltext

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma von Rochigneux, P., Nault, J.C., Ganne-Carrié, N., Olive, D.

Volltext

20PDynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma von Rochigneux, P, Nault, J C, Ganne-Carrié, N, Olive, D

Volltext

Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registry‐based study von Goldwasser, François, Vinant, Pascale, Aubry, Régis, Rochigneux, Philippe, Beaussant, Yvan, Huillard, Olivier, Morin, Lucas

Volltext

1058P Hyperprogressive disease during immune checkpoint inhibitor: A cloudy phenomenon with real consequences von Bruyat, D., Girard, N., Penel, N., Heudel, P-E., Gonçalves, A., Madroszyk Flandin, A-C., Gravis, G., Chanez, B., Collineau, B., Chrétien, A-S., Beaufils, M., Billon, E., Rochigneux, P.

Volltext

Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, regis... von Kempf, Emmanuelle, Tournigand, Christophe, Rochigneux, Philippe, Aubry, Régis, Morin, Lucas

Volltext

Use of chemotherapy near the end of life for solid cancers: What factors matter? von Rochigneux, P., Raoul, J.L., Morin, L.

Volltext

504O IMHOTEP Phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors: Results of the colorectal cancer cohort von de la Fouchardiere, C., Zaanan, A., Cohen, R., Le Sourd, S.M., Tougeron, D., Soularue, E., Dubreuil, O., Williet, N., Samalin-Scalzi, E., Piessen, G., Hautefeuille, V., Jary, M., Ben Abdelghani, M., Evesque, L., Rochigneux, P., Blanc, E., Bibeau, F., DeMontfort, A., Coutzac, C.

Volltext

1448P IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts von Fouchardiere, C. de la, Zaanan, A., Cohen, R., Le Sourd, S.M., Tougeron, D., Soularue, E., Dubreuil, O., Williet, N., Samalin-Scalzi, E., Piessen, G., Hautefeuille, V., Jary, M., Ben Abdelghani, M., Evesque, L., Rochigneux, P., Blanc, E., Bibeau, F., DeMontfort, A., Coutzac, C.

Volltext

781TiP AGADIR: A basket multicenter open-label phase II study evaluating the first in class TLR7/8 agonist BDB001 in combination with atezolizumab and stereotactic body radiation t... von Italiano, A., Coutzac Bergouignan, C., Pasquier, D., Rochigneux, P., Sablin, M.P., Gomez-Roca, C.A., Ghiringhelli, F., Metges, J-P., Toulmonde, M., Cousin, S., Pernot, S., Auzanneau, C., Lortal, B., Kind, M., Sargos, P., Batard, S., Petit, A., Gillon, P., Albert, S., Pulido, M.

Volltext

Burden of inpatient care and treatments in terminally-ill cancer patients: results from a population-based, retrospective study from administrative data in France von Morin, Lucas, Aubry, Regis, Beaussant, Yvan, Rochigneux, Philippe, Goldwasser, Francois, Tournigand, Christophe

Volltext

P1.04-33 Deep Phenotyping of Immune Populations Reveals Baseline Predictors of Pembrolizumab Efficacy in NSCLC on KEYNOTE-001 von Rochigneux, P., Lisberg, A., Garcia, A., Chretien, A.S., Fattori, S., Madroszyk, A., Tseng, A., Akingbemi, W., Gukasyan, J., Madrigal, J., Carroll, J., Noor, Z., Cummings, A., Olive, D., Garon, E.

Volltext

21P Mass cytometry reveals a population of exhausted CD8+ T cells associated with durvalumab/tremelimumab/vinorelbine efficacy in advanced cervical cancer (iMOVIE) von Bertucci, A., Maby, P., Rochigneux, P., Legrand, F., Cropet, C., Frenel, J-S., Le Tourneau, C., Hervieu, A., Coquan, E., De La Motte Rouge, T., Saada, E.B., Lavaud, P., Ben-Amara, A., Rouvière, M-S., Grassi, P., Gorvel, L., Goncalves, A., Olive, D., Chrétien, A-S.

Volltext

Use of chemotherapy near the end of life for solid cancers: What factorsmatter? von Rochigneux, P, Raoul, JL, Morin, L

Volltext

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC von Zhou, Nanruoyi, Velez, Maria A, Bachrach, Benjamin, Gukasyan, Jaklin, Fares, Charlene M., Cummings, Amy L., Lind-Lebuffe, Jackson P., Akingbemi, Wisdom O., Li, Debory Y., Brodrick, Paige M., Yessuf, Nawal M., Rettinger, Sarah, Grogan, Tristan, Rochigneux, Philippe, Goldman, Jonathan W., Garon, Edward B., Lisberg, Aaron

Volltext

Evaluation of rapid HIV testing strategies in under equipped laboratories in the Central African Republic von Ménard, Didier, Maïro, Amina, Mandeng, Marie-Joëlle, Doyemet, Placide, Koyazegbe, Thomas d’Aquin, Rochigneux, Christophe, Talarmin, Antoine

Volltext

SESSION 43: EMBRYOLOGY – EMBRYO CRYOPRESERVATION von Panagiotidis, Y., Kasapi, E., Goudakou, M., Papatheodorou, A., Pasadaki, T., Petousis, S., Nikolettos, N., Maroulis, G., Vanderzwalmen, P., Prapas, Y., Desai, N., Goldberg, J., Austin, C., Falcone, T., Nakagawa, K., Ojiro, Y., Takahashi, C., Sugiyama, R., Juen, H., Nishi, Y., Yoneda, Y., Shirai, A., Force, A., Schubert, B., Chomier, M., Sergeant, P., Lescaille, M., Rochigneux, S., Chassagnard, F., Rollet, J., Robert, F., Baucher, S., Sergeant, M. V., Ginon, J., Rodrigue, M., Nicollet, B., Barblett, H., Mehmet, D., Rebollar-Lazaro, I., Turner, S.

Volltext

Rhabdomyolyse révélant un corticosurrénalome von Roy, M., Rochigneux, S., Guillot, E., Cuilleron, M., Tostain, J., Cathébras, P.

Volltext